Wendy T. Stam

Leiden, ZH 2333CC, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

High-resolution cryo-EM structure of integrin αIIbβ3 bound to disease-causing maternal HPA-1a antibody that blocks integrin activation.

High-resolution cryo-EM structure of integrin αIIbβ3 bound to disease-causing maternal HPA-1a antibody that blocks integrin activation.

Journal: Science advances

Published: July 17, 2026

Targeting microRNA-132 protects against kidney fibrosis and restricts myofibroblast differentiation from cells of renin lineage.

Targeting microRNA-132 protects against kidney fibrosis and restricts myofibroblast differentiation from cells of renin lineage.

Journal: American journal of physiology. Cell physiology

Published: September 26, 2025

Maternal anti-HPA-1a antibodies block αIIbβ3 and αvβ3 integrin activation which correlates with FNAIT disease severity.

Maternal anti-HPA-1a antibodies block αIIbβ3 and αvβ3 integrin activation which correlates with FNAIT disease severity.

Journal: Blood

Published: September 16, 2025

Maternal anti-HPA-1a antibodies block αIIbβ3/αvβ3 integrin activation, and blockade correlates with FNAIT disease severity.

Maternal anti-HPA-1a antibodies block αIIbβ3/αvβ3 integrin activation, and blockade correlates with FNAIT disease severity.

Journal: Blood

Published: September 16, 2025

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3, and bind inactive integrins more strongly than active integrins.

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3, and bind inactive integrins more strongly than active integrins.

Journal: Blood

Published: April 15, 2025

Targeting long non-coding RNA MALAT1 preserves endothelial cell integrity and protects against kidney fibrosis.

Targeting long non-coding RNA MALAT1 preserves endothelial cell integrity and protects against kidney fibrosis.

Journal: Molecular therapy. Nucleic acids

Published: March 19, 2025

SCUBE2, where are you? Recruitment of SCUBE2 to adherens junctions preserves vascular health and integrity.

SCUBE2, where are you? Recruitment of SCUBE2 to adherens junctions preserves vascular health and integrity.

Journal: Cardiovascular research

Published: September 06, 2024

SGLT2 inhibition promotes glomerular repopulation by cells of renin lineage in experimental kidney disease.

SGLT2 inhibition promotes glomerular repopulation by cells of renin lineage in experimental kidney disease.

Journal: Acta physiologica (Oxford, England)

Published: September 13, 2023

Live-Cell Labeling and Artificial Intelligence Approaches for High-Resolution XYZT Imaging of Cytoskeletal Dynamics During Collective Cell Migration.

Live-Cell Labeling and Artificial Intelligence Approaches for High-Resolution XYZT Imaging of Cytoskeletal Dynamics During Collective Cell Migration.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 18, 2023

Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatment.

Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatment.

Journal: Blood reviews

Published: October 27, 2022

Impact of merging two university hospitals on surgical outcome after esophagogastric and hepato-pancreato-biliary surgery: Results from a retrospective study.

Impact of merging two university hospitals on surgical outcome after esophagogastric and hepato-pancreato-biliary surgery: Results from a retrospective study.

Journal: Surgery open science

Published: October 26, 2022

Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center.

Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: September 04, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026